Tirzepatide (50 mg)

What is Tirzepatide (50mg)?

Tirzepatide is a synthetic peptide used in laboratory research focused on metabolic signaling pathways. It is designed to model incretin-related biological activity in experimental systems. The compound consists of 39 amino acids and has a molecular weight of 4,813.48 g/mol. Research-grade preparations are typically manufactured to≥98% purity, confirmed by analytical testing. In controlled laboratory environments, Tirzepatide is studied to investigate mechanisms of metabolic signaling, glucose regulation, and energy balance. Researchers use this peptide to observe how hormone-like signals influence cellular metabolic processes. Its defined peptide structure and reproducible synthesis allow scientists to study endocrine signaling pathways under standardized experimental conditions.

What are the key features of Tirzepatide (50mg)?

• Purity: Typically ≥98%, verified using HPLC analysis
• Subcategory: Weight Loss & Metabolic Peptides
• CAS Number: 2023788-19-2
• Chemical Formula: C₂₂₅H₃₄₈N₄₈O₆₈
• Molecular Weight: 4813.48 g/mol
• Structure: Synthetic 39-amino acid peptide
• Peptide Sequence: Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys(C20-linker)-Ile-Ala-Gln-Lys-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂
• Format: Lyophilized powder in a 50 mg research vial
• Verification: Identity confirmed by mass spectrometry (MS)
• Research Classification: Investigated in metabolic and endocrine studies
• For laboratory research use only

How is Tirzepatide (50mg) synthesized?

Tirzepatide is produced using solid-phase peptide synthesis (SPPS), a technique that allows scientists to construct peptides with specific amino acid sequences. During this process, protected amino acids are sequentially added to a resin-bound chain, enabling the precise formation of the peptide structure. After synthesis, the peptide is purified by high-performance liquid chromatography (HPLC) to remove impurities and isolate the desired compound. Analytical confirmation is typically performed using mass spectrometry (MS) to verify the expected molecular weight and identity. The purified peptide is then lyophilized to produce a stable powder suitable for storage and research use.

What is Tirzepatide (50mg) being studied for? What are its possible benefits?

Tirzepatide has been investigated in laboratory research focused on metabolic and endocrine signaling pathways. Due to its engineered peptide structure, it has attracted interest in studies exploring how hormone-like molecules influence metabolic regulation. Research areas where Tirzepatide has been studied or is under investigation include:

• Metabolic signaling processes related to energy balance
• Glucose regulation pathways in experimental systems
• Hormone-mediated nutrient metabolism
• Appetite-related cellular signaling in laboratory models
• Body weight–associated metabolic responses in preclinical studies

These research efforts aim to better understand the role of peptide-based signaling molecules in metabolic regulation. Ongoing studies continue to examine how Tirzepatide interacts with complex biological systems.

How does Tirzepatide (50mg) work in research studies?

In laboratory investigations, Tirzepatide is studied for its interaction with hormone-related signaling mechanisms involved in metabolic processes. Researchers examine how the peptide may influence cellular pathways that coordinate energy utilization and nutrient processing. Experimental observations suggest that Tirzepatide may affect signaling pathways involved in metabolic communication between tissues and glucose-related cellular responses. By examining these interactions in controlled environments, scientists aim to gain insights into how peptide-based signaling molecules influence metabolic regulation.

What dosing information exists for Tirzepatide (50mg)?

Reported dosing ranges vary by experimental model. In preclinical animal research, Tirzepatide has been examined at doses ranging from approximately 0.03 mg/kg to 10 mg/kg, typically administered at scheduled intervals within controlled study protocols. In cell-based laboratory studies, investigators often examine peptide activity at nanomolar to micromolar concentrations to observe cellular responses. These experimental concentrations are selected based on the design of each laboratory study. It is important to note that no established dosing recommendations exist for human or veterinary use, as Tirzepatide, when provided in research form, is intended solely for scientific investigation.

How should Tirzepatide (50mg) be stored and handled?

Proper storage helps preserve peptide stability and maintain research quality. Tirzepatide is typically distributed as a lyophilized powder, which improves stability and reduces the risk of degradation during storage. Recommended storage guidelines include:

• Store the peptide at –20 °C or lower for long-term preservation
• Protect the vial from moisture, heat, and direct light
• After reconstitution, solutions are commonly stored at 2–8 °C for short-term research use
• Avoid repeated freeze–thaw cycles, which may affect peptide stability

Following these practices helps maintain the peptide's purity and structural integrity during laboratory experiments.

Where can I read more research about Tirzepatide (50mg)?

1. National Center for Biotechnology Information. PubChem Compound Summary for CID 156588324, Tirzepatide. https://pubchem.ncbi.nlm.nih.gov/compound/156588324
2. Sun B, Willard FS, Feng D, et al. Structural determinants of dual incretin receptor agonism by tirzepatide. Proc Natl Acad Sci U S A. 2022;119(13):e2116506119. doi:10.1073/pnas.2116506119
3. Coskun T, Sloop KW, Loghin C, et al. LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept. Mol Metab. 2018;18:3-14. doi:10.1016/j.molmet.2018.09.009
4. Chavda VP, Ajabiya J, Teli D, Bojarska J, Apostolopoulos V. Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review. Molecules. 2022;27(13):4315. Published 2022 Jul 5. doi:10.3390/molecules27134315
5. Tirzepatide: Uses, interactions, mechanism of action. DrugBank. https://go.drugbank.com/drugs/DB15171

Compliance Statement

This product is intended for laboratory research use only and is not approved for human or veterinary use.